2000”N
"ƒqƒg”’ŒŒ•a×–E‚j562×–E‚Ì×–E•ª‰»‚É‚¨‚¯‚鉻Šw§Œä"
¬ˆé–MŽq,’†“‡C,¼‘º‘å•ã,“¡–{N”V,‹´–{—Sˆê
–òŠwŽGŽ, 120, 104-112, (2000) |
"Cleavage and inactivation of antiapoptotic
Akt/PBK by caspases during apoptosis"
S. Rokudai, N. Fujita, Y. Hashimoto, and
T. Tsuruo
J. Cell. Physiol., 182, 290-296, (2000) |
"Modulators of tumor necrosis factor
a production bearing dicarba-closo-dodecaborane
as a hydrophobic pharmacophore"
M. Tsuji, Y. Koiso, H. Takahashi, Y. Hashimoto,
and Y. Endo
Biol. Pharm. Bull., 24, 513-516, (2000) |
"Structures of ADP-ribosylated rifampicin
and its metabolite; Intermediates of rifampicin-ribosylation
by Mycobacterium smegmatis DSM43756"
N. Morisaki, Y. Hashimoto, K. Furihata, T.
Imai, K. Watanabe, Y. Mikami, K. Yazawa,
A. Ando, Y. Nagata, and E. R. Dabbs
J. Antibiotics, 53, 269-275, (2000) |
"Concise asymmetric synthesis of dysidiolode"
M. Takahashi, K. Dodo, Y. Hashimoto, and
R. Shirai
Tetrahedron Lett., 41, 2111-2114, (2000) |
"Synthesis of a novel class of cdc25A
inhibitors from vitamin D3"
K. Dodo, M. Takahashi, Y. Hashimoto, Y. Sugimoto,
Y. Hashimoto and R. Shirai
Bioorg. Med. Chem. Lett., 10, 615-617, (2000) |
"Phosphorylation of unnatural phosphatidylinositols
with phosphatidylinositol 3-kinase"
N. Morisaki, K. Morita, A. Nishikawa, N.
Nakatsu, Y. Fukui, Y. Hashimoto and R. Shirai
Tetrahedron, 56, 2603-2614, (2000) |
"Glyoxalase I is involvedin resistance
of human leukemia cells to antitumor agent-induced
apoptpsis"
H. Sakamoto, T. Mashima, A. Kizaki, S. Dan,
Y. Hashimoto, and T. Tsuruo
Blood, 95, 3214-321, (2000) |
"Novel ƒ¿-glucosidase inhibitors with
a tetrachlorophthalimide skeleton"
S. Sou, S. Mayumi, H. Takahashi, R. Yamasaki,
S. Kadoya, M. Sodeoka and Y. Hashimoto
Bioorg. Med. Chem. Lett., 10, 1081-1084,
(2000) |
"Separation of phosphatidylinositol
4-phosphate from a mixture with phosphatidylserine
and phosphtidylinositol by Sep-pak C18 cartrige"
N. Morisaki, M. Masaoka, R. Shirai, and Y.
Hashimoto
Biol. Pharm. Bull., 23, 1088-1089, (2000) |
"Identification of protein disulfide
isomerase as a phorbol ester-binding
protein"
S. Mayumi, A. Azuma, H. Kobayashi, M. Sodeoka,
K. Yano, S. Sugimoto, Y. Endo, and Y. Hashimoto
Biol. Pharm. Bull., 23, 1111-1113, (2000) |
"‘n–ò‚̃pƒ‰ƒ_ƒCƒ€ƒVƒtƒg"
‹´–{—Sˆê
ŠÅŒì, 52, 92-95, (2000) |
"ƒ¿-Glucosidase inhibitors with a phthalimide
skeleton: Structure-activity relationship
study"
H. Takahashi, S. Sou, R. Yamasaki, M. Sodeoka,
and Y. Hashimoto
Chem. Pharm. Bull. 48, 1494-1499, (2000) |
"Retinoidal pyrimidinecarboxylic acids.
Unexpected diaza-substituent effects in retinobenzoic
acids"
K. Ohta, E. Kawachi, N. Inoue, H. Fukusawa,
Y. Hashimoto, A. Itai, and H. Kagechika
Chem. Pharm. Bull., 48, 1504, (2000) |
"ŠÂóƒCƒ~ƒh\‘¢‚ð—L‚·‚é“ÁˆÙ“IƒAƒ~ƒmƒyƒvƒ`ƒ_[ƒ[‘jŠQ܃Š[ƒh‚Ì‘n»"
‚‹´—T•Û,‘E“c³l,‰Á—ˆ“c”Ž‹M,‹´–{—Sˆê
YAKUGAKU@ZASSHI, 120, 909, (2000) |
"Bioprobes recognizing nucleic acids
and signal transduction factors"
Y. Hashimoto
Recent Rev. Devel. Organic Chem., 4,
87-120,
(2000) |
"Anti-androgenic activity of substituted
azo- and azoxy-benzene derivatives"
H. Takahashi, T.Ishioka, Y. Koiso, M. Sodeoka,
and Y. Hashimoto
Biol. Pharm. Bull., 23, 1387-1390, (2000) |
|
|